A5101714147- Gastroesophageal reflux and treatments
- Esophageal Cancer Research and Treatment
- Eosinophilic Esophagitis
- Esophageal and GI Pathology
- Gastrointestinal Bleeding Diagnosis and Treatment
- Helicobacter pylori-related gastroenterology studies
- Gastric Cancer Management and Outcomes
- Gastrointestinal disorders and treatments
- Gastrointestinal Tumor Research and Treatment
- Gastrointestinal motility and disorders
- Microbial metabolism and enzyme function
- Dysphagia Assessment and Management
- Advanced Glycation End Products research
- Eosinophilic Disorders and Syndromes
- Gallbladder and Bile Duct Disorders
- Acne and Rosacea Treatments and Effects
- Pancreatitis Pathology and Treatment
- Hepatitis C virus research
- Pancreatic and Hepatic Oncology Research
- Diabetes Treatment and Management
- Dermatological and COVID-19 studies
- Cancer-related gene regulation
- Neuroendocrine Tumor Research Advances
- melanin and skin pigmentation
- Colorectal Cancer Screening and Detection
All India Institute of Medical Sciences
2020
All India Institute of Medical Sciences Bhopal
2020
All India Institute of Medical Sciences Raipur
2020
Troy Gastroenterology
2010-2013
Mayo Clinic in Arizona
2001-2011
Center for Digestive and Liver Diseases
2010
Mayo Clinic Hospital
2009
Oregon Health & Science University
2008
Mayo Clinic
2002-2008
Beth Israel Deaconess Medical Center
2008
Endoscopy is commonly performed to evaluate for suspected or established esophageal diseases including gastroesophageal reflux disease (GERD) and its complications. The newly developed PillCam ESO Esophageal Capsule offers an alternative approach visualize the esophagus patients with disease.Compare accuracy (specificity, sensitivity, positive predictive value [PPV], negative [NPV]) of capsule endoscopy (ECE) compared esophagogastroduodenoscopy (EGD) in evaluating GERD.A multicenter pivotal...
OBJECTIVES Wireless video capsule endoscopy (CE) is a new technology that allows visualization of the entire small intestinal mucosa. It indicated for evaluation obscure gastrointestinal bleeding (OGIB) and other disorders intestine. Studies to date suggest CE safe associated with few adverse events. A concern, which has not been studied, potential effect on implanted cardiac devices such as implantable defibrillators (ICD) electromedical devices. We previously found be in patients...
Recent reports have suggested that patients with rosacea, a chronic inflammatory skin disorder of unknown etiology, an increased prevalence Helicobacter pylori infection. However, no causal relation has been identified. This study was designed to determine the H. infection and upper gastrointestinal symptoms in rosacea subjects without disorders.Forty-five 43 healthy underwent serological testing for Demographics, symptoms, medication use were recorded using structured questionnaire.There...
Increasingly, primary care (PC) physicians will be the first to encounter patients with hepatitis C virus (HCV) infection.To determine opinions and practices of PC residents regarding HCV.We administered a one-page questionnaire 180 at five U.S. training programs.Respondents were distributed equally across postgraduate year, 83% graduates, 44% had seen >11 in past year. Residents tested for HCV persons with: increased transaminases (83%), history blood transfusion (46%), multiple tattoos...
Competence in gastrointestinal (GI) endoscopy correlates with the number of procedures performed by endoscopist. For each GI endoscopic procedure, American Society for Gastrointestinal Endoscopy (ASGE) guidelines recommend minimum numbers needed to assess competence.We conducted an anonymous mail survey determine whether centers United States follow ASGE or other granting and renewing privileges.Completed surveys were received from 479 respondents 46 states, Puerto Rico, District Columbia....
Aim: To compare the 24‐h intragastric pH effects of simplified lansoprazole suspension, 30 mg, administered nasogastrically, with pantoprazole, 40 intravenously. Methods: Thirty‐six healthy adults were enrolled and given mg (nasogastrically), or (intravenously), once daily for five consecutive days in a cross‐over fashion. Intragastric was monitored at baseline on Days 1 5 each treatment period. The pharmacokinetic parameters pantoprazole also determined 5. Results: No statistically...